Search clinical trials for: Tesmilifene (YMB1002)

Total 6 results

YM BioSciences

Completed

Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer

Metastatic Breast Cancer

Serbia
YM BioSciences

Completed

Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer

Metastatic/Recurrent Breast Cancer

Russian Federation, Georgia, Ukraine
Shaanxi Micot Technology Limited Company

Terminated

MT1002 Phase II Study in ACS Patients With PCI

Acute Coronary Syndrome

United States
Shaanxi Micot Technology Limited Company

Terminated

Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics

ACS - Acute Coronary Syndrome

United States
Shaanxi Micot Technology Limited Company

Completed

Single Ascending Dose Trial to Evaluate the Safety, Tolerability, PK, and PD of MT1002 for Injection

Healthy

United States
King's College Hospital NHS Trust
Medical Research Council

Not yet recruiting

Hepatocyte Microbeads for Acute Liver Failure (HELP)

Acute Liver Failure

3

Subscribe